Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse MKT  >  IGI LABORIGI       

End-of-day quote. End-of-day quote Nyse MKT - 08/13
5.99 USD   +3.63%
06/09 IGI LABORATORIE : Announces Fourth ANDA Submission of 2015
05/28 IGI LABORATORIE : Announces Third ANDA Submission Of 2015
05/27 IGI LABORATORIE : Updates Business Outlook
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the development and commercialization of pharmaceutical products

IGI Laboratories, Inc. develops, manufactures and markets topical formulations.

The company sells generic topical pharmaceutical products under IGI label.

It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.

The company's products are used in a wide range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis, and eczema.

IGI Laboratories was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Number of employees : 81 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Topical Formulations18.22100%33.74100% +45.99%
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States18.22100%33.74100% +45.99%
Managers
NameAgeSinceTitle
Jason Grenfell-Gardner, MBA402012President, Chief Executive Officer & Director
James C. Gale, MBA652009Chairman
Sanjay Samudre-2013Operations Director
Jenniffer L. Collins, CPA452011Chief Financial Officer & Secretary
Narendra N. Borkar, MBA742009Independent Director
Bhaskar Chaudhuri, PhD602010Independent Director
Steven Hubrig Koehler MBA, CPA642014Independent Director
John E. Celentano, MBA552015Independent Director
Thomas Vandervort-2014Vice President-Business Development
Shareholders
NameShares%
Signet Healthcare Partners LLC 9,851,861 18.6%
Janus Capital Management LLC 5,287,990 10.0%
Amzak Capital Management LLC 4,574,576 8.65%
Stephen J. Morris 2,843,849 5.38%
Ranger Investment Management LP 2,828,775 5.35%
Pembroke Management Ltd. 2,491,554 4.71%
Allianz Global Investors U.S. LLC 2,126,596 4.02%
BlackRock Fund Advisors 1,746,335 3.30%
Kopp Investment Advisors LLC 1,520,775 2.88%
Wells Capital Management, Inc. 1,287,582 2.44%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ALLERGAN PLC
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
GLAXOSMITHKLINE P..
ELI LILLY AND CO
VALEANT PHARMACEU..
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
MYLAN NV
ASTELLAS PHARMA I..
Sector Pharmaceuticals
IGI LABORIGI : Connections
Anteis SA
Catholic Medical Mission Board, Inc.
Alpex Pharma SA
Frazier Healthcare Ventures
Latshaw Enterprises, Inc.
Inspire Pharmaceuticals, Inc.
Cedarburg Hauser Pharmaceuticals, Inc.
J.J. White, Inc.
Arbor Pharmaceuticals, Inc.
Thesan Pharmaceuticals, Inc.
SpePharm AG
Silvergate Pharmaceuticals, Inc.
Bionpharma, Inc.
Frazier Management LLC
Sanders Morris Harris Group Private Equity
Amylin Pharmaceuticals, Inc.
Signet Healthcare Partners LLC
YourEncore, Inc.
IGI, Inc. /Companion Pet Products Division/
The Pennington School
Company contact information
IGI Laboratories, Inc.
105 Lincoln Avenue
Buena, NJ 08310

Phone : +1.856.697.1441
Fax : +1.856.697.2259
Web : www.igilabs.com
© 2015 People , Fundamentals and Ownership